10 employees
Aequor develops anti-biofilm and anti-fouling molecules, engaging in research and development of chemicals from marine microbes.
2006
$53K
from 2 investors over 2 rounds
AEQUOR, Inc. raised undisclosed on April 27, 2021
Investors: Seldor Capital
AEQUOR, Inc. raised $53K on December 1, 2016
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)